Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
Nature Medicine2000Vol. 6(10), pp. 1176–1182
Citations Over TimeTop 1% of 2000 papers
Ludwig Kappos, Giancarlo Comi, Hillel Panitch, Joël Oger, Jack P. Antel, Paul Conlon, Lawrence Steinman, Gıancarlo Comı, Ludwig Kappos, Joël Oger, Hillel Panitch, Alexander Rae‐Grant, John Castaldo, Nancy Eckert, Joseph Guarnaccia, P. Mills, Gary M. Johnson, Peter A. Calabresi, Carlo Pozzilli, Stefano Bastianello, Elisabetta Giugni, Tatiana Witjas, Patrick J. Cozzone, Jean Pelletier, Dieter Pöhlau, H. Przuntek, Volker Hoffmann, Christopher T. Bever, Eleanor Katz, M. Clanet, I. Berry, David Brassat, I. Brunet, Gilles Edan, Pierre Duquette, Ernst‐Wilhelm Radue, Dagmar Schött, Carmen Lienert, Alice Taksaoui, M. Rodegher, Massimo Filippi, Alan C. Evans, Pierre Bourgouin, Alex Zijdenbos, Shawki Salem, Nicholas Ling, David G. Alleva, Eric B. Johnson, Amitabh Gaur, Paul D. Crowe, Xin-Jun Liu
Related Papers
- → Developmental regulation of myelin basic protein in dispersed cultures(1981)112 cited
- → Cerebrospinal Fluid Myelin Basic Protein and Multiple Sclerosis(1978)24 cited
- → THE ENCEPHALITOGENIC ACTIVITY AND MYELIN BASIC PROTEIN CONTENT OF ISOLATED OLIGODENDROGLIA(1977)17 cited
- → Human T lymphocytes reactive with whole myelin recognize predominantly myelin basic protein(1989)11 cited
- → Hyperreactivity to myelin basic protein in multiple sclerosis(1981)4 cited